SEC Filing Details

Document Details

Form
Filing Date
Feb 3, 2021
Document Date
Dec 31, 2020
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.
Filer
Kazam Joshua A
Print Page
Email Alerts
RSS Feeds
Investor Contacts